ALOX5 and familial pancreatic carcinoma: Inhibition of ALOX5 by low-dose Zileuton led to the inhibition of invasion and metastasis in PANC-1 pancreatic cancer cells, and mitigated the M2-like phenotype through the JAK/STAT pathway in macrophages [232].